Circulating MicroRNAs to Predict the Risk for Metabolic Diseases in the General Population?

Circulating MicroRNAs to Predict the Risk for Metabolic Diseases in the General Population?

Metabolic syndrome (MetS) results from the cluster of several risk factors, including central obesity, insulin resistance, dyslipidemia, and hypertension. Around 20%-25% of the world's adult population is estimated to have MetS. MetS has been estimated to confer a fivefold increase in the risk...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Diabetes (New York, N.Y.) N.Y.), 2017-03, Vol.66 (3), p.565-567
Hauptverfasser: Dumas, Marc-Emmanuel, Emanueli, Costanza
Format: Artikel
Sprache:eng
Schlagworte:
Cardiovascular disease
Circulating MicroRNA
Diabetes
Humans
Hypertension
Insulin resistance
Metabolic Diseases
Metabolic Syndrome - epidemiology
MicroRNAs
Obesity
Risk
Risk factors
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Metabolic syndrome (MetS) results from the cluster of several risk factors, including central obesity, insulin resistance, dyslipidemia, and hypertension. Around 20%-25% of the world's adult population is estimated to have MetS. MetS has been estimated to confer a fivefold increase in the risk of type 2 diabetes (T2D) over the next 5-10 years. Both MetS and T2D increase the risk of cardiovascular disease.
ISSN:0012-1797
1939-327X
DOI:10.2337/dbi16-0072